Intravenous Bevacizumab Causes Regression of Choroidal Neovascularization Secondary to Diseases Other Than Age-related Macular Degeneration

PURPOSE: To investigate the safety, tolerability, and bioactivity of intravenous infusions of bevacizumab in patients with choroidal neovascularization (CNV) attributable to causes other than age-related macular degeneration. DESIGN: Nonrandomized clinical trial. METHODS: Ten patients with CNV recei...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Ophthalmol
Egile Nagusiak: NGUYEN, QUAN DONG, SHAH, SYED MAHMOOD, HAFIZ, GULNAR, DO, DIANA V., HALLER, JULIA A., PILI, ROBERTO, ZIMMER-GALLER, INGRID E., JANJUA, KASHIF, SYMONS, R. C. ANDREW, CAMPOCHIARO, PETER A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2007
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868052/
https://ncbi.nlm.nih.gov/pubmed/18054887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2007.09.025
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak